Improving the Sensitivity and Selectivity of Laser Desorption Ionization Using N-Heterocyclic Carbene Mass Ionization Tags
Project Number1R21GM155773-01
Contact PI/Project LeaderCAMDEN, JON
Awardee OrganizationUNIVERSITY OF NOTRE DAME
Description
Abstract Text
PROJECT SUMMARY
Even two decades after the complete sequencing of the human genome, a significant subpopulation (~10%) of
the encoded proteins remains unknown. The questions surrounding this “dark” proteome are further
compounded because there is not a one-to-one correspondence between genes and proteins and the function
of expressed proteins can be changed by hundreds of different types of post-translational modifications. The
resulting protein variants, or proteoforms, could be in the millions and may appear at concentrations well below
the detection limit of current methods. Mass spectrometry (MS) is one of most powerful tools in the modern
proteomics toolbox; however, MS only measures things that can be ionized and promoted to the gas phase,
highlighting the importance of the ionization process. Today, measurement of high-abundance proteins is a trivial
task for modern mass spectrometers, but closer examination reveals that low-abundance proteoforms
comprising the “dark” proteome remain elusive. Therefore, new measurement capabilities are urgently needed
that can increase the sensitivity and selectivity of the ionization process. While improvements in MS
instrumentation are expected to continue, a parallel approach relying on chemical methods to increase sensitivity
would provide a synergistic route to detect low abundance proteoforms. Here, we outline a high-risk but high-
reward strategy for improving the ionization efficiency of these low abundance peptides and post-translationally
modified peptides. Specifically, proof-of-concept experiments will demonstrate that N-heterocyclic carbene
(NHC) decorated gold nanoparticles (AuNPs) are an excellent platform for the selective capture and fragment-
free ionization of peptides, delivering at least two orders of magnitude improvement over state-of-the-art
methods. Additionally, we will demonstrate that these NHC-AuNPs can improve the detection of post-
translationally modified proteins and are compatible with pre-existing proteomics workflows employing
bioorthogonal click chemistries. Lastly, while the proof-of-concept studies proposed here target bottom-up MS
proteomics applications, the NHC mass tag platform is quite general and would have broader implications for
MS applications ranging from tissue and single-cell imaging to disease biomarker identification and detection.
Public Health Relevance Statement
PROJECT NARRATIVE
The identification and quantification of low-abundance and post-translationally modified proteins is a formidable
and unmet challenge with tremendous potential to impact human health. The proposed research will develop a
new chemical platform employing N-heterocyclic carbenes and gold nanoparticles to improve the ionization
efficiency of peptides, which is critical for elucidating protein structure. This increased sensitivity has the potential
to reveal new disease biomarkers and provide a protein-level view of cellular functions.
No Sub Projects information available for 1R21GM155773-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21GM155773-01
Patents
No Patents information available for 1R21GM155773-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21GM155773-01
Clinical Studies
No Clinical Studies information available for 1R21GM155773-01
News and More
Related News Releases
No news release information available for 1R21GM155773-01
History
No Historical information available for 1R21GM155773-01
Similar Projects
No Similar Projects information available for 1R21GM155773-01